BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16642477)

  • 1. Genetic aberrations in prostate cancer by microarray analysis.
    Saramäki OR; Porkka KP; Vessella RL; Visakorpi T
    Int J Cancer; 2006 Sep; 119(6):1322-9. PubMed ID: 16642477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.
    Wolf M; Mousses S; Hautaniemi S; Karhu R; Huusko P; Allinen M; Elkahloun A; Monni O; Chen Y; Kallioniemi A; Kallioniemi OP
    Neoplasia; 2004; 6(3):240-7. PubMed ID: 15153336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
    Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
    Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
    van Duin M; van Marion R; Watson JE; Paris PL; Lapuk A; Brown N; Oseroff VV; Albertson DG; Pinkel D; de Jong P; Nacheva EP; Dinjens W; van Dekken H; Collins C
    Cytometry A; 2005; 63(1):10-9. PubMed ID: 15619731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetics of prostate cancer.
    Nupponen NN; Visakorpi T
    Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
    Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
    Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
    van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
    Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization.
    Wolter H; Gottfried HW; Mattfeldt T
    BJU Int; 2002 Feb; 89(3):310-6. PubMed ID: 11856117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
    Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
    Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Yuri K; Shuin T
    Cancer Genet Cytogenet; 2002 Aug; 137(1):59-63. PubMed ID: 12377415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
    Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
    PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.